Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button

Home > Press > AlphaRx to Deliver Product Pipeline Updates at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

Abstract:
AlphaRx Inc. , a leading specialty pharmaceutical company with a unique focus on nanotechnology delivery platforms, will update the medical and investor communities on its product pipeline at the 9th Annual Healthcare Conference in New York, November 5-7, at the Plaza Hotel. Dr. David Milroy, the Director of Medical Research at AlphaRx, will provide detailed reports on the complete product pipeline including Clinical trial updates. Dr. Milroy will also present the latest information on Vansolin(TM), which targets nosocomial pneumonia and has a market value estimate of $3.6 billion. Dr. Milroy will present on Wednesday November 7th at 1:00 p.m. (Eastern Time) in the Kennedy II Room.

AlphaRx to Deliver Product Pipeline Updates at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

MARKHAM, ON, Canada | Posted on November 1st, 2007

A live webcast of AlphaRx's presentation can be accessed by logging onto
http://www.wsw.com/webcast/rrshq12/alrx .

A replay of the presentation will be archived for 90 days after the conference, at the same site. For more information, please visit http://www.rodmanandrenshaw.com .

####

About AlphaRx Inc.
AlphaRx is a specialty pharmaceutical company utilizing proprietary site-specific nanoparticulate drug delivery systems to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method. The Company also discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and neurodegenerative diseases.

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are meant to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. While management believes such representation to be true and accurate based on the information available to the company, actual results may differ materially from those described. The company's operations and business prospects are always subject to risks and uncertainties. Important facts that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

For more information, please click here

Contacts:
168 Konrad Crescent
Suite 200, Markham
Ontario, Canada L3R 9T9
Phone: 905/479-3245
Fax: 416/352-6120
Email:

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016

A new way to display the 3-D structure of molecules: Metal-organic frameworks provide a new platform for solving the structure of hard-to-study samples August 21st, 2016

Curbing the life-long effects of traumatic brain injury August 19th, 2016

Lab team spins ginger into nanoparticles to heal inflammatory bowel disease August 19th, 2016

Announcements

New theory could lead to new generation of energy friendly optoelectronics: Researchers at Queen's University Belfast and ETH Zurich, Switzerland, have created a new theoretical framework which could help physicists and device engineers design better optoelectronics August 23rd, 2016

New flexible material can make any window 'smart' August 23rd, 2016

University of Puerto Rico and NASA back in the news XEI reports August 23rd, 2016

Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016

Events/Classes

Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016

Impressive List of Doctors, Scientists Coming to Vail for Scientific Summit: The Second Vail Scientific Summit Convenes the Greatest Minds in Regenerative Medicine and Science August 17th, 2016

Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016

Pokhara, the second largest city of Nepal, to host its first ever International Meeting on Material Sciences and Engineering August 15th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic